Related Experiment Video
Updated: Oct 23, 2025

An Intact Pericardium Ischemic Rodent Model
Published on: September 2, 2021
Coronavirus Disease 2019 (COVID-19) and Severe Pericardial Effusion: From Pathogenesis to Management: A Case Report
Mohammad Kermani-Alghoraishi1, Alireza Pouramini1, Fatemeh Kafi2
1Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Insights
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can cause life-threatening pericardial effusion in COVID-19 patients. This review examines its varied presentations and emphasizes the need for medical management and follow-up.
Area of Science:
- Cardiology
- Infectious Diseases
- Pathology
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, extends beyond respiratory symptoms to affect cardiac health.
- Pericardial effusion, particularly large effusions causing tamponade, is a critical complication observed in some COVID-19 patients.
Observation:
- This systematic review analyzes case reports of moderate to severe pericardial effusion with tamponade physiology in COVID-19.
- Pathogenesis involves direct viral invasion, inflammation, cytokine storms, and oxidative stress from ARDS.
Findings:
- Pericardial effusion manifestations are variable, appearing as delayed complications, with myocarditis/pericarditis, isolated, or with ARDS.
- Percutaneous pericardiocentesis was frequently performed, revealing exudative fluid (hemorrhagic, serous, or serosanguinous).
Implications:
- Understanding the varied presentations of SARS-CoV-2-associated pericardial effusion is crucial for timely diagnosis.
- Medical treatment and close follow-up are recommended, particularly for patients with concurrent pericarditis.
Abstract:
The Severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) created a global pandemic that continues to this day. In addition to pulmonary symptoms, the virus can have destructive effects on other organs, especially the heart. For example, large pericardial effusion has been observed as a critical and life-threatening finding in Coronavirus disease of 2019 (COVID-19) patients. In this case report based systematic review, we review the reports of moderate to severe pericardial effusion associated with tamponade physiology. Direct cardiomyocyte and pericardium invasion, inflammation and cytokine storms and oxidative stress due to acute respiratory distress syndrome, are the pathogenesis of this phenomenon. The results showed that the manifestations of this finding are variable. Pericardial effusion can be seen as a delayed complication, accompanied by myocarditis or pericarditis, isolated, or with acute respiratory distress syndrome. In most patients, emergency percutaneous pericardiocentesis was performed, and fluid analysis was often exudative in 3 pattern of hemorrhagic, serous, and serosanguinous. Medical treatment and follow-up are recommended, especially in cases of pericarditis.
More Related Videos
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis IV: Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

